Price (delayed)
$1.2
Market cap
$14.04M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.92
Enterprise value
-$4.87M
Synlogic™ is bringing the transformative potential of synthetic biology to medicine. With a premiere synthetic biology platform that leverages a reproducible, modular approach to microbial engineering, Synlogic designs Synthetic Biotic
There are no recent dividends present for SYBX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.